NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway (original) (raw)
References
Abeysinghe H.R, Cedrone E, Tyan T, Xu J, Wang N . (1999). Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH. Cancer Genet Cytogenet114: 136–143. ArticleCAS Google Scholar
Abhiman S, Iyer LM, Aravind L . (2008). BEN: a novel domain in chromatin factors and DNA viral proteins. Bioinformatics24: 458–461. ArticleCAS Google Scholar
Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller D . (1990). c-myc amplification in ovarian cancer. Gynecol Oncol38: 340–342. ArticleCAS Google Scholar
Bourguignon LY, Peyrollier K, Xia W, Gilad E. . (2008). Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem283: 17635–17651. ArticleCAS Google Scholar
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell122: 947–956. ArticleCAS Google Scholar
Cha XY, Pierce RC, Kalivas PW, Mackler SA . (1997). NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci17: 6864–6871. ArticleCAS Google Scholar
Chung HK, Yi YW, Jung NC, Kim D, Suh JM, Kim H et al. (2003). CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. J Biol Chem278: 28079–28088. ArticleCAS Google Scholar
Davidson B, Berner A, Trope CG, Wang TL, Shih Ie M . (2007). Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions. Hum Pathol38: 1030–1036. ArticleCAS Google Scholar
De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R., Jones J et al. (2001). Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature414: 308–313. ArticleCAS Google Scholar
Dimova I, Raitcheva S, Dimitrov R, Doganov N, Toncheva D . (2006). Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours. Eur J Cancer42: 674–679. ArticleCAS Google Scholar
Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT et al. (2003). Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res9: 2778–2785. CAS Google Scholar
Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A et al. (2006a). Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res12: 5055–5063. ArticleCAS Google Scholar
Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV . (2006b). GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemother Pharmacol57: 25–33. ArticleCAS Google Scholar
Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ et al. (2002). Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol87: 8–16. ArticleCAS Google Scholar
Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N et al. (2008). A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer. Clin Cancer Res14: 3149–3155. ArticleCAS Google Scholar
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . (2007). Cancer statistics, 2007. CA Cancer J Clin57: 43–66. Article Google Scholar
Kalivas PW, Duffy P, Mackler SA . (1999). Interrupted expression of NAC-1 augments the behavioral responses to cocaine. Synapse33: 153–159. ArticleCAS Google Scholar
Kim J, Chu J, Shen X, Wang J, Orkin SH . (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell132: 1049–1061. ArticleCAS Google Scholar
Koob G.F . (1996). Drug addiction: the yin and yang of hedonic homeostasis. Neuron16: 893–896. ArticleCAS Google Scholar
Korutla L, Degnan R, Wang P, Mackler SA . (2007). NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST. J Neurochem101: 611–618. ArticleCAS Google Scholar
Korutla L, Wang PJ, Mackler SA . (2005). The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures. J Neurochem94: 786–793. ArticleCAS Google Scholar
Liu GH, Wang SR, Wang B, Kong BH . (2006). Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line. Int J Gynecol Cancer16: 1777–1782. ArticleCAS Google Scholar
Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML . (2003). Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol189: 1301–1307. Article Google Scholar
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T et al. (2004). Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem279: 23477–23485. ArticleCAS Google Scholar
Mackler S, Pacchioni A, Degnan R, Homan Y, Conti AC., Kalivas P et al. (2008). Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response. Behav Brain Res187: 48–55. ArticleCAS Google Scholar
Mackler SA, Korutla L, Cha XY, Koebbe MJ, Fournier KM, Bowers MS et al. (2000). NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci20: 6210–6217. ArticleCAS Google Scholar
Mao TL, Hsu CY, Yen MJ, Gilks B, Sheu JJ, Gabrielson E et al. (2006). Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum Pathol37: 1169–1175. ArticleCAS Google Scholar
Materna V, Surowiak P, Kaplenko I, Spaczynski M, Duan Z, Zabel M et al. (2007). Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients. Virchows Arch450: 187–194. ArticleCAS Google Scholar
Muller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C et al. (2008). Regulatory networks define phenotypic classes of human stem cell lines. Nature455: 401–405. Article Google Scholar
Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE et al. (2006a). Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol Ther5: 630–634. ArticleCAS Google Scholar
Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A et al. (2006b). A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci USA103: 18739–18744. ArticleCAS Google Scholar
Nakayama K, Nakayama N, Wang T-L, Shih I-M . (2007). NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor. Cancer Res67: 8058–8064. ArticleCAS Google Scholar
Qiu W, Zhou B, Zou H, Liu X, Chu PG, Lopez R et al. (2004). Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Am J Pathol165: 1689–1699. ArticleCAS Google Scholar
Shih Ie M, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE et al. (2005). Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci USA102: 14004–14009. Article Google Scholar
Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M et al. (2001). Inhibition of JNK activation through NF-kappaB target genes. Nature414: 313–317. ArticleCAS Google Scholar
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S et al. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature380: 75–79. ArticleCAS Google Scholar
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW et al. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature444: 364–368. ArticleCAS Google Scholar
Yeasmin S, Nakayama K, Ishibashi M, Katagiri A, Iida K, Purwana IN et al. (2008). Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis. Clin Cancer Res14: 1686–1691. ArticleCAS Google Scholar
Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK et al. (2005). The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res11: 6442–6449. ArticleCAS Google Scholar
Yusuf RZ, Duan Z, Lamendola DE, Penson RT, Seiden MV . (2003). Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets3: 1–19. ArticleCAS Google Scholar
Zerbini LF, Libermann TA . (2005a). GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets. Clin Cancer Res11: 6409–6413. ArticleCAS Google Scholar
Zerbini LF, Libermann TA . (2005b). Life and death in cancer. GADD45 alpha and gamma are critical regulators of NF-kappaB mediated escape from programmed cell death. Cell Cycle4: 18–20. ArticleCAS Google Scholar
Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K et al. (2004). NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci USA101: 13618–13623. ArticleCAS Google Scholar
Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res68: 4311–4320. ArticleCAS Google Scholar